Actively Recruiting
Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
Led by Ciceri Fabio · Updated on 2025-05-13
500
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
Sponsors
C
Ciceri Fabio
Lead Sponsor
G
Gruppo Italiano Trapianto di Midollo Osseo
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a retrospective and prospective non-interventional multicenter observational study. Neither diagnostic approaches nor experimental drugs/procedure will be applied and the samples will take place at the same time as the samples will be taken during routinary clinical practice. The aim of this study is to analyze the immunobiology of Acute Myeloid Leukemia (AML) relapses after allogeneic HSCT for the generation of guidelines and personalized therapeutic pathways.
CONDITIONS
Official Title
Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with Acute Myeloid Leukemia who relapse after allogeneic transplantation from family or unrelated donors, regardless of transplant cell source, and who have signed informed consent
- For the coordinating center, patients who have signed informed consent for the Hematological Neoplasms Biobank and have samples stored in the Biobank
- For other centers, patients who have signed informed consent for sample storage in their center's biobank and have samples available
You will not qualify if you...
- Participation in clinical protocols that exclude involvement in other studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Ospedale San Raffaele
Milan, Milano, Italy, 20132
Actively Recruiting
Research Team
F
Fabio Ciceri, MD
CONTACT
S
Stefania Trinca
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here